For clinicians in home health, the patient encounter is only half the job. The other half is the documentation: the OASIS forms, the progress notes, the compliance checks that can turn a 30-minute visit into a 90-minute administrative slog. It is a burden that directly subtracts from patient care, and it is the precise wedge a new Brooklyn-based startup, StenoHealth, is using to enter one of healthcare's most fragmented and paper-heavy sectors.
Founded in 2024, StenoHealth has built an AI-driven software platform aimed at home-health and chronic-care providers. Its core offering, Steno Doc, uses ambient listening and natural language processing to convert clinician-patient conversations into structured clinical notes. A companion tool, Steno QA, automatically reviews those notes for regulatory compliance and completeness. The company's early traction, however, is defined less by a standalone product and more by a strategic embedding. In 2026, StenoHealth partnered with Homecare Homebase (HCHB), a leading electronic health record (EHR) platform for post-acute care, to launch Curate: Scribe, a natively integrated AI documentation solution within the HCHB system [Homecare Homebase Announces Curate: Scribe, retrieved 2026].
The wedge of workflow integration
For a startup targeting the home health space, the decision to build an integrated feature, rather than a standalone application, is a calculated one. The home care workflow is notoriously complex, governed by specific Medicare reimbursement rules and assessment frameworks like OASIS. Clinicians are often pressed for time and resistant to switching between multiple applications. By embedding directly into HCHB's EHR, which is used by a significant portion of the home health industry, StenoHealth bypasses the adoption friction of a new tool. Clinicians can access AI-assisted documentation without leaving their primary system, a critical detail for usability and adoption.
The partnership suggests StenoHealth is pursuing a platform-as-a-service model for its AI. The company also offers a Steno API, described as a secure, clinically-aware AI infrastructure layer for post-acute care, handling orchestration, compliance, and data deletion [Home Health Care Software - StenoHealth, retrieved 2024]. This indicates an ambition to power AI features for other healthcare software vendors, not just end-user agencies.
The team behind the bet
The founding team brings a blend of clinical and technical expertise, which is non-negotiable for navigating the regulated healthcare landscape. CEO Alex Milani holds both an MD and an MBA, providing the necessary lens on both patient care and business operations [Alex Milani, MD, MBA - LinkedIn, retrieved 2026]. Co-founder and COO Bharat V Reddy brings an engineering background in mechatronics and robotics [Bharat Reddy Contact Information, retrieved 2026]. The company's initial $498,000 in pre-seed funding came from Europa, an investor that appears to have backed the venture at its earliest stage [Steno - 2025 Funding Rounds, retrieved 2026].
| Founder / Key Leader | Role | Background Note |
|---|---|---|
| Alex Milani | Co-founder & CEO | MD, MBA [LinkedIn, 2026] |
| Bharat V Reddy | Co-founder & COO | Bachelor of Engineering in Mechatronics [ZoomInfo, 2026] |
| Pavel Tseluyko | CEO (per some sources) | Listed as CEO on some organizational charts [The Org, 2024] |
Note: Some public sources list Pavel Tseluyko as CEO, while others point to Alex Milani. This may reflect an evolution in leadership titles common at early-stage companies.
Beyond documentation to whole-patient care
StenoHealth's platform extends beyond note-taking. The company has also built modules for Remote Patient Monitoring (RPM) and Chronic Care Management (CCM), two growing areas in value-based care. The RPM tools allow agencies to track patient vitals and symptoms between visits, while the CCM module helps coordinate care plans and patient communication [Perplexity Sonar Pro Brief, retrieved 2024]. These are not afterthoughts; they represent a coherent product thesis. By starting with the documentation pain point,the gateway into the clinical workflow,StenoHealth aims to position itself as the intelligence layer for the entire home-based care continuum, from assessment to ongoing management.
The risks of regulated terrain
The ambition is clear, but the path is lined with the typical hurdles of health tech, amplified by the specific sensitivities of home care. StenoHealth's success hinges on several variables where missteps could stall momentum.
- Regulatory and reimbursement uncertainty. While AI documentation tools are gaining FDA clearance in other settings (like emergency departments), their use in home health for billing purposes sits in a grayer area. Medicare's rules for what constitutes a billable note are strict, and any perceived automation of clinical judgment could raise flags. The company's QA tool is a direct response to this, but ultimate acceptance rests with payers and auditors.
- Integration depth and scalability. The HCHB partnership is a powerful beachhead, but its value depends on the depth of the integration and its adoption across HCHB's client base. A shallow integration that requires significant manual workarounds will not solve the clinician's problem. Furthermore, the home health tech stack is fragmented; winning in HCHB does not guarantee access to agencies using other major EHRs like Homecare Homebase's competitors.
- The data moat question. The long-term defensibility of clinical AI often lies in proprietary datasets that improve model accuracy. It is unclear from public materials how StenoHealth is building its unique training corpus or whether its models are fine-tuned specifically on home health encounters, which have distinct patterns compared to hospital or clinic visits.
The company's most plausible answer to these challenges is its partnership-first, embedded approach. By working within the established workflow and regulatory framework of a major EHR, it shares the compliance burden with a seasoned player. HCHB has a vested interest in ensuring Curate: Scribe meets industry standards.
The next twelve months
The immediate future for StenoHealth will be measured in deployments and data. The rollout of Curate: Scribe within HCHB will be the primary traction signal to watch. Early metrics on clinician time saved, note accuracy, and user adoption within those pilot agencies will be crucial for validating the product-market fit and attracting the next round of funding. Given the capital-intensive nature of AI development and healthcare sales, a Seed round is a likely milestone within the next year. The company will also need to demonstrate that its RPM and CCM tools see uptake, proving the platform can expand beyond its documentation wedge.
For the clinicians and patients at the heart of this, the stakes are tangible. The standard of care in home health today is often a race against the clock. A nurse or therapist spends valuable face-to-face time with a patient, then must retreat to a car or office to complete pages of detailed documentation, often duplicating efforts across systems. This burden contributes to burnout and can subtly shift focus from holistic care to checkbox completion. StenoHealth's bet is that by reclaiming those hours lost to paperwork, it can help agencies improve both clinician satisfaction and patient outcomes. The disease states here are the chronic, often complex conditions that bring patients into home care in the first place,congestive heart failure, COPD, diabetes, post-surgical recovery. The patient population is typically older, with multiple comorbidities, relying on the home as their primary site of care. If the AI works as intended, it won't just make charts faster; it might help keep those patients healthier, at home, and out of the hospital.
Sources
- [Perplexity Sonar Pro Brief, retrieved 2024] StenoHealth Product Overview | https://www.stenohealth.com/
- [Home Health Care Software - StenoHealth, retrieved 2024] StenoHealth Platform Description | https://www.stenohealth.com/
- [Homecare Homebase Announces Curate: Scribe, retrieved 2026] Partnership Announcement | https://www.linkedin.com/in/emma-trumbull-pt-ms-cspo-55901834/
- [Alex Milani, MD, MBA - LinkedIn, retrieved 2026] Executive Background | https://www.linkedin.com/in/alexandermilani/
- [Bharat Reddy Contact Information, retrieved 2026] Executive Background | https://www.zoominfo.com/p/Bharat-Reddy/-
- [The Org, retrieved 2024] Leadership Listings | https://theorg.com/org/stenohealth/org-chart/pavel-tseluyko